Viewing nowEsomedin Tablet 20mg (Esomeprazole Magnesium Trihydrate)
Esomeprazole Magnesium Trihydrate 21.69mg
Tablet · Prescription medication
GL Pharma Co., Ltd.

MFDS item code 201907455 · Approved 2019.10.25 · Insurance code 649702370
Treatment and prevention of gastroesophageal reflux, gastrointestinal disorders (ulcers, eradication therapy, etc.), and Zollinger-Ellison syndrome
This medication is used for long-term maintenance therapy to treat gastroesophageal reflux disease, particularly erosive esophagitis, and to prevent its recurrence. It is also helpful in alleviating symptoms of gastroesophageal reflux disease without esophagitis. It is effective for the treatment and prevention of duodenal ulcers and peptic ulcers when used in combination with antibiotics for the eradication of Helicobacter pylori. It is used for short-term treatment of upper gastrointestinal symptoms related to the use of non-steroidal anti-inflammatory drugs, as well as for the treatment of gastric ulcers due to prolonged use, and for the prevention of gastric and duodenal ulcers. It is applied for the treatment of Zollinger-Ellison syndrome and maintenance therapy to prevent rebleeding from gastric or duodenal ulcers, improving patients' symptoms.
Administer 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, continue treatment for another 4 weeks. Long-term maintenance treatment to prevent recurrence in patients with esophagitis: 20 mg once daily Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Once symptoms have resolved, subsequent recurring symptoms may be controlled with 20 mg once daily. In adults, 20 mg may be administered once daily as needed. As-needed administration to control recurring symptoms is not recommended in patients at high risk of gastric and duodenal ulcers associated with NSAID use. Administer this medicine 20 mg with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Clinical studies lasting longer than 4 weeks have not been conducted. Treatment of gastric ulcers associated with NSAID use: 20 mg once daily. The treatment period is 4∼8 weeks. Prevention of gastric and duodenal ulcers associated with NSAID use: 20 mg once daily. The recommended initial dose is 40 mg twice daily. The subsequent dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses exceeding 80 mg per day should be divided into 2 doses. Administer 40 mg once daily for 4 weeks following initiation of prevention of rebleeding from gastric or duodenal ulcers by intravenous injection.
Adolescents aged 12 years and older - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, continue treatment for another 4 weeks. Adolescents aged 12 years and older - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is required. Adolescents aged 12 years and older - Once symptoms have resolved, subsequent recurring symptoms may be controlled with 20 mg once daily. Children under 12 years of age - There is no experience with administration of this medicine to children under 12 years of age.
This medication should not be used in certain patients. For example, those who have had an allergic reaction or hypersensitivity to this medication or its ingredients should avoid taking it. Caution is needed for patients taking certain antibiotics or medications, especially when combined with some antibiotics. It is advisable for pregnant or breastfeeding women not to use this medication. This medication may cause various side effects such as blood-related abnormalities, allergic reactions, gastrointestinal disturbances, and neurological symptoms, so if symptoms occur, patients should consult healthcare professionals immediately. Regular check-ups are necessary during prolonged use, particularly regarding magnesium levels and fracture risk. This medication can interact with other drugs, so it is important to inform healthcare professionals of any other medications being taken. Pregnant women should use this medication cautiously and it is safer not to use it while breastfeeding. In cases of overdose, there is no specific antidote, so patients should visit a hospital immediately for appropriate treatment. When storing this medication, keep it out of reach of children and do not transfer it to other containers.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, anxiety, mental confusion, depression, aggressiveness, hallucination, headache, dizziness, paresthesia, drowsiness, taste disorder, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, increased liver enzymes, jaundice, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, drug reaction with eosinophilia and systemic symptoms, fracture, arthralgia, myalgia, muscle weakness, idiopathic membranous nephropathy, gynecomastia, asthenia, increased sweating, Clostridium difficile-related diarrhea, abdominal distension, allergic reaction, back pain, chest pain, sternal pain, facial swelling, facial flushing, fatigue, influenza-like illness, generalized edema, leg edema, lethargy, pain, rigidity, flushing, hypertension, tachycardia, thyroid enlargement, irritable bowel syndrome, worsening constipation, dyspepsia, dysphagia, gastrointestinal malformation, epigastric pain, belching, esophageal disorder, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, melena, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, increased serum gastrin, tongue disorders, tongue swelling, ulcerative stomatitis, earache, tinnitus, anemia, hypopigmented anemia, cervical lymphadenopathy, nosebleed, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver dysfunction, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, thirst, vitamin B12 deficiency, weight gain, weight loss, worsening arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, polymyalgia rheumatica, anorexia, apathy, increased appetite, confusion, exacerbation of depression, hypertonia, sensory impairment, erectile dysfunction, insomnia, migraine, worsening migraine, sleep disorders, tremors, visual field defects, dysmenorrhea, menstrual disorders, vulvovaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, erythematous rash, papular rash, otitis media, olfactory disturbance, loss of taste, taste abnormality, urinary irregularities, albuminuria, cystitis, dysuria, fungal infection, hematuria, frequency of urination, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, hypocalcemia, hypokalemia, rhabdomyolysis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from exposure to air and moisture. It is advisable to maintain storage temperature between 1 degree and 30 degrees Celsius at room temperature.
Pale pink, round film-coated tablet
28 tablets (14 tablets/PTP x 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Trihydrate 21.69mg
Tablet · Prescription medication
GL Pharma Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.